Literature DB >> 8527383

Distinct Xp11.2 breakpoints in two renal cell carcinomas exhibiting X;autosome translocations.

T Dijkhuizen1, E van den Berg, M Wilbrink, M Weterman, A Geurts van Kessel, S Störkel, R P Folkers, A Braam, B de Jong.   

Abstract

Several human renal cell carcinomas with X;autosome translocations have been reported in recent years. The t(X;1)(p11.2;q21) appears to be a specific primary anomaly, suggesting that tumors with this translocation form a distinct subgroup of RCC. Here we report two new cases, one with a t(X;10)(p11.2;q23), the other with a t(X;1)(p11.2;p34). The common breakpoint in Xp11.2 suggests that they belong to the above-mentioned subset of RCC. Using FISH in conjunction with X-specific YAC clones, we demonstrate that the two new cases exhibited distinct breakpoints within Xp11.2.

Entities:  

Mesh:

Year:  1995        PMID: 8527383     DOI: 10.1002/gcc.2870140108

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  Renal cell carcinoma with t(X;17)(p11.2;q25) in a 5-year-old Taiwanese boy: a case report and review of the literature.

Authors:  Chih-Jung Chen; Hui-Ting Hsu; Ming-Tsan Lin; Mariann Pintye; Jim-Ray Chen
Journal:  Pathol Oncol Res       Date:  2011-01-08       Impact factor: 3.201

2.  Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas.

Authors:  M A Weterman; M Wilbrink; A Geurts van Kessel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

3.  Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangement.

Authors:  Minghao Zhong; Paul Weisman; Bing Zhu; Maria Brassesco; Youfeng Yang; W Marston Linehan; Maria J Merino; David Zhang; Stephen Rohan; Dongming Cai; Ximing Yang
Journal:  Diagn Mol Pathol       Date:  2013-06

4.  Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas.

Authors:  M A Weterman; J J van Groningen; L Tertoolen; A G van Kessel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

5.  Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.

Authors:  Malcolm Hayes; Kvetoslava Peckova; Petr Martinek; Milan Hora; Kristyna Kalusova; Lubomir Straka; Ondrej Daum; Bohuslava Kokoskova; Pavla Rotterova; Kristyna Pivovarčikova; Jindrich Branzovsky; Magdalena Dubova; Pavla Vesela; Michal Michal; Ondrej Hes
Journal:  Virchows Arch       Date:  2014-12-28       Impact factor: 4.064

6.  TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.

Authors:  Pedram Argani; Minghao Zhong; Victor E Reuter; John T Fallon; Jonathan I Epstein; George J Netto; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-06       Impact factor: 6.394

7.  Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma.

Authors:  Melinda E Sanders; Rosemarie Mick; John E Tomaszewski; Frederic G Barr
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

8.  [Pediatric renal cell carcinoma].

Authors:  E Bruder; H Moch
Journal:  Pathologe       Date:  2004-07       Impact factor: 1.011

9.  Alveolar soft part sarcomas: molecular pathogenesis and implications for novel targeted therapies.

Authors:  Bryan Mitton; Noah Federman
Journal:  Sarcoma       Date:  2012-04-08

10.  Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.

Authors:  Dinesh Pradhan; Somak Roy; Gabriela Quiroga-Garza; Kathleen Cieply; Alyssa L Mahaffey; Sheldon Bastacky; Rajiv Dhir; Anil V Parwani
Journal:  Diagn Pathol       Date:  2015-09-29       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.